Role of spinal P2Y6 and P2Y11 receptors in neuropathic pain in rats: Possible involvement of glial cells

Molecular Pain

Volumn 10, Issue 1, 2014, Pages

  Barragán Iglesias, Paulino ^a   Pineda Farias, Jorge B ^a   Cervantes Durán, Claudia ^a   Bravo Hernández, Mariana ^a   Rocha González, Héctor I ^b   Murbartián, Janet ^a   Granados Soto, Vinicio ^a  

^a DEPARTAMENTO DE FÍSICA   (Mexico)

^b INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Astrocytes; Microglia; Neuropathic pain; P2Y11 receptors; P2Y6 receptors; Spinal cord

Indexed keywords

FLUOROCITRIC ACID; MEMBRANE PROTEIN; MINOCYCLINE; PROTEIN IBA 1; PURINERGIC P2Y11 RECEPTOR; PURINERGIC P2Y6 RECEPTOR; UNCLASSIFIED DRUG;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DRUG MECHANISM; FEMALE; MALE; MICROGLIA; NEUROPATHIC PAIN; NEUROPATHOLOGY; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RAT; SPINAL CORD; UPREGULATION;

EID: 84901652229     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-10-29     Document Type: Article

References (57)

1. Chizh BA, Illes P. P2X receptors and nociception. Pharmacol Rev 2001, 53:553-568.
2. Wirkner K, Sperlagh B, Illes P. P2X3 receptor involvement in pain states. Mol Neurobiol 2007, 36:165-183. 10.1007/s12035-007-0033-y, 17952660.
3. Bleehen T, Keele CA. Observations on the algogenic actions of adenosine compounds on the human blister base preparation. Pain 1977, 3:367-377. 10.1016/0304-3959(77)90066-5, 198725.
4. Hamilton SG, Warburton J, Bhattacharjee A, Ward J, McMahon SB. ATP in human skin elicits a dose-related pain response which is potentiated under conditions of hyperalgesia. Brain 2000, 123(Pt 6):1238-1246.
5. Hilliges M, Weidner C, Schmelz M, Schmidt R, Orstavik K, Torebjork E, Handwerker H. ATP responses in human C nociceptors. Pain 2002, 98:59-68. 10.1016/S0304-3959(01)00469-9, 12098617.
6. Jarvis MF, Wismer CT, Schweitzer E, Yu H, van Biesen T, Lynch KJ, Burgard EC, Kowaluk EA. Modulation of BzATP and formalin induced nociception: attenuation by the P2X receptor antagonist, TNP-ATP and enhancement by the P2X3 allosteric modulator, cibacron blue. Br J Pharmacol 2001, 132:259-269. 10.1038/sj.bjp.0703793, 1572551, 11156585.
7. Sawynok J. Adenosine and ATP receptors. Handb Exp Pharmacol 2007, 177:309-328.
8. Nakagawa T, Wakamatsu K, Zhang N, Maeda S, Minami M, Satoh M, Kaneko S. Intrathecal administration of ATP produces long-lasting allodynia in rats: differential mechanisms in the phase of the induction and maintenance. Neuroscience 2007, 147:445-455. 10.1016/j.neuroscience.2007.03.045, 17543465.
9. Kage K, Niforatos W, Zhu CZ, Lynch KJ, Honore P, Jarvis MF. Alteration of dorsal root ganglion P2X3 receptor expression and function following spinal nerve ligation in the rat. Exp Brain Res 2002, 147:511-519. 10.1007/s00221-002-1263-x, 12444483.
10. Ueno S, Yamada H, Moriyama T, Honda K, Takano Y, Kamiya HO, Katsuragi T. Measurement of dorsal root ganglion P2X mRNA by SYBR Green fluorescence. Brain Res Brain Res Protoc 2002, 10:95-101. 10.1016/S1385-299X(02)00187-3, 12431708.
11. Sharp CJ, Reeve AJ, Collins SD, Martindale JC, Summerfield SG, Sargent BS, Bate ST, Chessell IP. Investigation into the role of P2X3/P2X2/3 receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study. Br J Pharmacol 2006, 148:845-852. 1617075, 16770326.
12. Xiang Z, Xiong Y, Yan N, Li X, Mao Y, Ni X, He C, LaMotte RH, Burnstock G, Sun J. Functional up-regulation of P2X3 receptors in the chronically compressed dorsal root ganglion. Pain 2008, 140:23-34. 10.1016/j.pain.2008.07.006, 2667225, 18715715.
13. Zhang X, Chen Y, Wang C, Huang LY. Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia. Proc Natl Acad Sci U S A 2007, 104:9864-9869. 10.1073/pnas.0611048104, 1887586, 17525149.
14. Gosselin RD, Suter MR, Ji RR, Decosterd I. Glial cells and chronic pain. Neuroscientist 2010, 16:519-531. 10.1177/1073858409360822, 3017463, 20581331.
15. Kim C, Chung JM, Chung K. Changes in the gene expression of six subtypes of P2X receptors in rat dorsal root ganglion after spinal nerve ligation. Neurosci Lett 2003, 337:81-84. 10.1016/s0304-3940(02)01302-2, 12527393.
16. Inoue K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol Ther 2006, 109:210-226. 10.1016/j.pharmthera.2005.07.001, 16169595.
17. North RA. Molecular physiology of P2X receptors. Physiol Rev 2002, 82:1013-1067.
18. Donnelly-Roberts D, McGaraughty S, Shieh CC, Honore P, Jarvis MF. Painful purinergic receptors. J Pharmacol Exp Therapeut 2008, 324:409-415.
19. Kobayashi K, Takahashi E, Miyagawa Y, Yamanaka H, Noguchi K. Induction of the P2X7 receptor in spinal microglia in a neuropathic pain model. Neurosci Lett 2011, 504:57-61. 10.1016/j.neulet.2011.08.058, 21924325.
20. Romero-Sandoval A, Chai N, Nutile-McMenemy N, Deleo JA. A comparison of spinal Iba1 and GFAP expression in rodent models of acute and chronic pain. Brain Res 2008, 1219:116-126. 2512259, 18538310.
21. Echeverry S, Shi XQ, Zhang J. Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain. Pain 2008, 135:37-47. 10.1016/j.pain.2007.05.002, 17560721.
22. Milligan ED, Watkins LR. Pathological and protective roles of glia in chronic pain. Nat Rev Neurosci 2009, 10:23-36. 10.1038/nrn2533, 2752436, 19096368.
23. Inoue K, Tsuda M. Purinergic systems, neuropathic pain and the role of microglia. Exp Neurol 2012, 234:293-301. 10.1016/j.expneurol.2011.09.016, 21946271.
24. Clark AK, Malcangio M. Microglial signalling mechanisms: Cathepsin S and Fractalkine. Exp Neurol 2012, 234:283-292. 10.1016/j.expneurol.2011.09.012, 21946268.
25. Xiao HS, Huang QH, Zhang FX, Bao L, Lu YJ, Guo C, Yang L, Huang WJ, Fu G, Xu SH, Cheng XP, Yan Q, Zhu ZD, Zhang X, Chen Z, Han ZG, Zhang X. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A 2002, 99:8360-8365. 10.1073/pnas.122231899, 123072, 12060780.
26. Malin SA, Davis BM, Koerber HR, Reynolds IJ, Albers KM, Molliver DC. Thermal nociception and TRPV1 function are attenuated in mice lacking the nucleotide receptor P2Y2. Pain 2008, 138:484-496. 10.1016/j.pain.2008.01.026, 2630699, 18343036.
27. Tozaki-Saitoh H, Tsuda M, Miyata H, Ueda K, Kohsaka S, Inoue K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci 2008, 28:4949-4956. 10.1523/JNEUROSCI.0323-08.2008, 18463248.
28. Kobayashi K, Yamanaka H, Yanamoto F, Okubo M, Noguchi K. Multiple P2Y subtypes in spinal microglia are involved in neuropathic pain after peripheral nerve injury. Glia 2012, 60:1529-1539. 10.1002/glia.22373, 22736439.
29. Magni G, Ceruti S. P2Y purinergic receptors: new targets for analgesic and antimigraine drugs. Biochem Pharmacol 2013, 85:466-477. 10.1016/j.bcp.2012.10.027, 23146663.
30. Caram-Salas NL, Reyes-Garcia G, Bartoszyk GD, Araiza-Saldaña CI, Ambriz-Tututi M, Rocha-González HI, Arreola-Espino R, Cruz SL, Granados-Soto V. Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat. Eur J Pharmacol 2007, 573:75-83. 10.1016/j.ejphar.2007.06.034, 17643411.
31. Mamedova LK, Joshi BV, Gao ZG, von Kugelgen I, Jacobson KA. Diisothiocyanate derivatives as potent, insurmountable antagonists of P2Y6 nucleotide receptors. Biochem Pharmacol 2004, 67:1763-1770. 10.1016/j.bcp.2004.01.011, 3413726, 15081875.
32. Meis S, Hamacher A, Hongwiset D, Marzian C, Wiese M, Eckstein N, Royer HD, Communi D, Boeynaems JM, Hausmann R, Schmalzing G, Kassack MU. NF546 [4,4'-(carbonylbis(imino-3,1-phenylene-carbonylimino-3,1-(4-methyl-phenylene)-car bonylimino))-bis(1,3-xylene-alpha, alpha'-diphosphonic acid) tetrasodium salt] is a non-nucleotide P2Y11 agonist and stimulates release of interleukin-8 from human monocyte-derived dendritic cells. J Pharmacol Exp Therapeut 2010, 332:238-247.
33. Okada M, Nakagawa T, Minami M, Satoh M. Analgesic effects of intrathecal administration of P2Y nucleotide receptor agonists UTP and UDP in normal and neuropathic pain model rats. J Pharmacol Exp Therapeut 2002, 303:66-73.
34. Fricks IP, Maddileti S, Carter RL, Lazarowski ER, Nicholas RA, Jacobson KA, Harden TK. UDP is a competitive antagonist at the human P2Y14 receptor. J Pharmacol Exp Therapeut 2008, 325:588-594.
35. Kobayashi K, Fukuoka T, Yamanaka H, Dai Y, Obata K, Tokunaga A, Noguchi K. Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord. J Comp Neurol 2006, 498:443-454. 10.1002/cne.21066, 16874807.
36. Yu J, Sheung N, Soliman EM, Spirli C, Dranoff JA. Transcriptional regulation of IL-6 in bile duct epithelia by extracellular ATP. Am J Physiol Gastrointest Liver Physiol 2009, 296:G563-G571. 10.1152/ajpgi.90502.2008, 2660176, 19136380.
37. Brandenburg LO, Jansen S, Wruck CJ, Lucius R, Pufe T. Antimicrobial peptide rCRAMP induced glial cell activation through P2Y receptor signalling pathways. Mol Immunol 2010, 47:1905-1913. 10.1016/j.molimm.2010.03.012, 20392497.
38. Ohtomo K, Shatos MA, Vrouvlianis J, Li D, Hodges RR, Dartt DA. Increase of intracellular Ca2+ by purinergic receptors in cultured rat lacrimal gland myoepithelial cells. Invest Ophthalmol Vis Sci 2011, 52:9503-9515. 10.1167/iovs.11-7809, 3341118, 22039237.
39. Alkayed F, Kashimata M, Koyama N, Hayashi T, Tamura Y, Azuma Y. P2Y11 purinoceptor mediates the ATP-enhanced chemotactic response of rat neutrophils. J Pharmacol Sci 2012, 120:288-295. 10.1254/jphs.12173FP, 23182888.
40. Sanada M, Yasuda H, Omatsu-Kanbe M, Sango K, Isono T, Matsuura H, Kikkawa R. Increase in intracellular Ca2+ and calcitonin gene-related peptide release through metabotropic P2Y receptors in rat dorsal root ganglion neurons. Neuroscience 2002, 111:413-422. 10.1016/S0306-4522(02)00005-2, 11983326.
41. Ruan HZ, Burnstock G. Localisation of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem Cell Biol 2003, 120:415-426. 10.1007/s00418-003-0579-3, 14564529.
42. LeBlanc BW, Zerah ML, Kadasi LM, Chai N, Saab CY. Minocycline injection in the ventral posterolateral thalamus reverses microglial reactivity and thermal hyperalgesia secondary to sciatic neuropathy. Neurosci Lett 2011, 498:138-142. 10.1016/j.neulet.2011.04.077, 21571034.
43. Mika J, Osikowicz M, Makuch W, Przewlocka B. Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain. Eur J Pharmacol 2007, 560:142-149. 10.1016/j.ejphar.2007.01.013, 17307159.
44. Mei XP, Xu H, Xie C, Ren J, Zhou Y, Zhang H, Xu LX. Post-injury administration of minocycline: an effective treatment for nerve-injury induced neuropathic pain. Neurosci Res 2011, 70:305-312. 10.1016/j.neures.2011.03.012, 21515316.
45. Nazemi S, Manaheji H, Zaringhalam J, Sadeghi M, Haghparast A. Post-injury repeated administrations of minocycline improve the antinociceptive effect of morphine in chronic constriction injury model of neuropathic pain in rat. Pharmacol Biochem Behav 2012, 102:520-525. 10.1016/j.pbb.2012.07.001, 22789876.
46. Bastos LF, Godin AM, Zhang Y, Jarussophon S, Ferreira BC, Machado RR, Maier SF, Konishi Y, de Freitas RP, Fiebich BL, Watkins LR, Coelho MM, Moraes MF. A minocycline derivative reduces nerve injury-induced allodynia, LPS-induced prostaglandin E2 microglial production and signaling via toll-like receptors 2 and 4. Neurosci Lett 2013, 543:157-162. 3678288, 23523650.
47. Raghavendra V, Tanga F, DeLeo JA. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy. J Pharmacol Exp Therapeut 2003, 306:624-630.
48. Padi SS, Kulkarni SK. Minocycline prevents the development of neuropathic pain, but not acute pain: possible anti-inflammatory and antioxidant mechanisms. Eur J Pharmacol 2008, 601:79-87. 10.1016/j.ejphar.2008.10.018, 18952075.
49. Zhang X, Xu Y, Wang J, Zhou Q, Pu S, Jiang W, Du D. The effect of intrathecal administration of glial activation inhibitors on dorsal horn BDNF overexpression and hind paw mechanical allodynia in spinal nerve ligated rats. J Neural Transm 2012, 119:329-336. 10.1007/s00702-011-0713-7, 21901501.
50. Milligan ED, Twining C, Chacur M, Biedenkapp J, O'Connor K, Poole S, Tracey K, Martin D, Maier SF, Watkins LR. Spinal glia and proinflammatory cytokines mediate mirror-image neuropathic pain in rats. J Neurosci 2003, 23:1026-1040.
51. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
52. Kim SH, Chung JM. An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat. Pain 1992, 50:355-363. 10.1016/0304-3959(92)90041-9, 1333581.
53. Chaplan SR, Bach FW, Pogrel JW, Chung JM, Yaksh TL. Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 1994, 53:55-63. 10.1016/0165-0270(94)90144-9, 7990513.
54. Dixon WJ. Efficient analysis of experimental observations. Annu Rev Pharmacol Toxicol 1980, 20:441-462. 10.1146/annurev.pa.20.040180.002301, 7387124.
55. Yaksh TL, Rudy TA. Chronic catheterization of the spinal subarachnoid space. Physiol Behav 1976, 17:1031-1036. 10.1016/0031-9384(76)90029-9, 14677603.
56. El-Tayeb A, Qi A, Muller CE. Synthesis and structure-activity relationships of uracil nucleotide derivatives and analogues as agonists at human P2Y2, P2Y4, and P2Y6 receptors. J Med Chem 2006, 49:7076-7087. 10.1021/jm060848j, 17125260.
57. Koizumi S, Shigemoto-Mogami Y, Nasu-Tada K, Shinozaki Y, Ohsawa K, Tsuda M, Joshi BV, Jacobson KA, Kohsaka S, Inoue K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature 2007, 446:1091-1095. 10.1038/nature05704, 3464483, 17410128.